Objective: To present prenatal diagnosis of chromosome 1p32-p31 deletion syndrome with NFIA haploinsufficiency, ventriculomegaly, corpus callosum hypogenesis, abnormal external genitalia, and intrauterine growth restriction and to review the literature. Materials, Methods, and Results: A 26-year-old, primigravid woman was referred for amniocentesis at 30 weeks of gestation because of hydrocephalus and short limbs. Prenatal ultrasound showed macrocephaly, prominent forehead, ventriculomegaly, corpus callosum hypogenesis, micrognathia, and ambiguous external genitalia. Amniocentesis was performed, and array comparative genomic hybridization using uncultured amniocytes revealed a 22.2-Mb deletion of 1p32.3-p31.1 [arr cgh 1p32.3p31.1 (55,500,291 bpe77,711,982 bp)Â1] encompassing the genes of NFIA, GPR177, and 89 additional genes. Cytogenetic analysis revealed a karyotype of 46,XX,del(1)(p31.1p32.3)dn. At 33 weeks of gestation, a dead fetus was delivered with a body weight of 1536 g (<5 th centile); relative macrocephaly; a broad face; prominent forehead; hypertelorism; anteverted nostrils; micrognathia; low-set ears; and abnormal female external genitalia with labial fusion, labial hypertrophy, absence of vaginal opening, and clitoral hypertrophy. Polymorphic DNA marker analysis determined a paternal origin of the deletion. Conclusion: Prenatal diagnosis of ventriculomegaly with an abnormal corpus callosum should alert subtle chromosome aberrations and prompt molecular cytogenetic investigation if necessary. Fetuses with chromosome 1p32-p31 deletion syndrome and haploinsufficiency of the NFIA gene may present ventriculomegaly, corpus callosum hypogenesis, abnormal external genitalia, and intrauterine growth restriction in the third trimester.
Introduction
Chromosome 1p32-p31 deletion syndrome [Online Mendelian Inheritance in Man (OMIM) 613735], a contiguous gene deletion syndrome, is associated with haploinsufficiency of the NFIA gene. The gene NFIA (OMIM 600727) locates at 1p31.3-p31.2 and encodes nuclear factor IA (NFIA) protein.
Chromosome 1p32-p31 deletion syndrome is characterized by macrocephaly; hydrocephalus/ventriculomegaly; hypoplastic/ absent corpus callosum; developmental delay; urinary tract defects such as vesicoureteral reflux and urinary incontinence; facial dysmorphism of a broad face with prominent forehead, low-set ears, a small mouth and chin, anteverted nostrils, a high palate and sparse eyebrows, and variable features of pigmentary retinopathy; inguinal hernia; cryptorchidism; polydactyly; hip dysplasia; and cutis marmorata [1, 2] . To date, only seven cases with chromosome 1p32-p31 deletion syndrome have been reported [1e5] , and all were diagnosed in infancy or childhood. Herein, we present an additional case, which, to our knowledge, is the first prenatally diagnosed case with chromosome 1p32-p31 deletion syndrome. We also review the literature.
Materials, methods, and results
A 26-year-old, primigravid woman was referred for amniocentesis at 30 weeks of gestation because of hydrocephalus and short limbs. Her husband was 29-year-old, and there was no family history of congenital malformations. Prenatal ultrasound at 30 weeks of gestation revealed a biparietal diameter of 7.91 cm (31.89 weeks), an abdominal circumference of 23.49 cm (27.81 weeks), a femur length of 4.88 cm (26.4 weeks), prominent forehead, micrognathia, ambiguous external genitalia, ventriculomegaly, and corpus callosum hypogenesis (Fig. 1 ). Other internal organs were unremarkable. Ultrafast magnetic resonance imaging showed ventriculomegaly and hypoplasia of the splenium of corpus callosum (Fig. 2) . Amniocentesis was performed at 30 weeks of gestation, and 56 mL of amniotic fluid was aspired, of which 20 mL was for array comparative genomic hybridization (aCGH) using uncultured amniocytes, 20 mL for culture and conventional cytogenetic analysis, and 12 mL for mutational analysis of the FGFR3 gene. (Fig. 3) . Subsequent conventional cytogenetic analysis revealed a karyotype of 46,XX,del(1)(p31.1p32.3)dn (Fig. 4) . The parental karyotypes were normal. Fluorescence in situ hybridization analysis using bacterial artificial chromosome clone probes RP11-31P4 (61,339,876e61,527,391 bp) (spectrum red) at 1p31.3 encompassing the NFIA gene and RP11-438F14 (spectrum green) at 1q44 as internal control showed absence of the red signal in the del(1) (p31.1p32.3) chromosome (Fig. 5) . The fluorescence in situ hybridization result was consistent with haploinsufficiency of the NFIA gene. Mutational analysis of the FGFR3 gene revealed no mutation and thus excluded achondroplasia. At 33 weeks of gestation, a dead fetus was delivered with a body weight of 1536 g (<5 th centile); a body length of 41 cm (<5 th centile); relative macrocephaly; a broad face; prominent forehead; hypertelorism; anteverted nostrils; micrognathia; low-set ears; and ambiguous external genitalia with labial fusion, labial hypertrophy, absence of vaginal opening, and clitoral Table 1 ).
Discussion
The de novo deletion of 22.2 Mb encompassing 1p32.3-p31.1 in the present case mainly affects the proximal region of 1p32.3, the entire regions of 1p32.2, 1p32.1, 1p31.3, and 1p31.2, and the distal region of 1p31.1. A critical region for hypoplastic/absent corpus callosum and ventriculomegaly has been proposed at 1p31.3-p31.2 in a series of five patients of chromosome 1p32-p31 deletion syndrome with haploinsufficiency of the NFIA gene [1] . Table 2 shows the clinical findings of eight individuals, including the present case with chromosome 1p32-p31 deletion syndrome.
Sivasankaran et al [3] first reported the association of interstitial deletion of chromosome 1p with absent corpus callosum. The baby girl had a karyotype of 46,XX,del(1)(p22p32)dn, absent corpus callosum, ocular hypertelorism, low-set ears, upturned nostrils, mesomelic shortening of the limbs, hypoplastic labia minora, and absent clitoris, and the clinical features were similar to chromosome 1p32-p31 deletion syndrome. Campbell et al [4] and Lu et al [1] reported two half-siblings with a maternally inherited unbalanced interstitial deletion of del(1)(p31.2p32.3) encompassing a region of 12 Mb and containing the entire NFIA gene and 47 additional genes. Both patients exhibited ventriculomegaly or hydrocephalus, a thin or agenesis of the corpus callosum (ACC), syringomelia, a tethered spinal cord, and/or left vesicoureteral reflux. Shanske et al [5] and Lu et al [1] reported a boy with a 12-Mb deletion of 2q14.3/q21 involving 39 genes and a reciprocal translocation of t(1;2)(p31.3;q22.1) involving a 3.9-kb breakpoint between Exons 7 and 8 of the NFIA gene. The patient exhibited hypoplastic corpus callosum, nonprogressive ventriculomegaly, and a gray matter heterotopia. Lu et al [1] investigated two new cases with chromosome 1p32-p31 deletion syndrome in addition to three cases previously reported by Campbell et al [4] and Shanske et al [5] . The first new case was a 6-year-old girl with congenital hydrocephalus, a thin corpus callosum, Type I Chiari malformation, a tethered spinal cord, a low vertebral deformity, congenital bilateral dysplastic kidneys, bilateral ureterovesical reflux, hydronephrosis, and a karyotype of 46,XX,t(1;20)(p31.3;q13.31)dn. In that case, the breakpoint at 1p31.3 had disrupted Intron 2 of the NFIA gene. The second new case presented ACC and ventriculomegaly on second trimester ultrasound and manifested additional abnormalities of a tethered spinal cord, Type I Chiari malformation, and dysplasia of the anterior left temporal fossa in childhood. The patient had a karyotype of 46,XY,t(1;3)(p31.1;q25.1) del(1)(p31.
Radiological examinations showed hypoplastic corpus callosum, ventriculomegaly, a large retrocerebellar cyst, and hypoplastic cerebellar vermis.
The present case had haploinsufficiency of the NFIA gene. There are four independent NFI genes in mammals: NFIA (OMIM 600727), NFIB (OMIM 600728), NFIC (OMIM 600729), and NFIX (OMIM 164005) [6] . NFI proteins act as cellular transcription/replication factors and play a key role in central nervous system development, including axonal outgrowth, and guidance as well as glial and neuronal cell differentiation [7] . NFIA has been shown to be highly expressed in heart, liver, brain, lung, ovary, skeletal muscle, kidney, testis, pancreas, spleen, and fetal liver and brain [8] . das Neves et al [9] found that disruption of the NFIA gene in mice caused perinatal lethality. They also found that the rare surviving homozygous NFIA À/À mice had absent corpus callosum, hydrocephalus, neurological defects, male sterility, and low female fertility. Shu et al [10] found altered formation of forebrain midline glial structure and commissural projections in NFIA knockout mice. Deneen et al [11] found that NFIA regulated gliogenesis and oligodendrocyte differentiation in developing spinal cord. Plachez et al [12] found that in addition to regulating the formation of axon guidance substrates, NFIA has a cell-autonomous role in cortical development. Lu et al [1] additionally found that NFIA haploinsufficiency can cause central nervous system malformation and urinary tract defects.
The present case also had haploinsufficiency of the GPR177 gene. GPR177, the mouse orthologue or Drosaphila Wntless/ Evi/Srt, is required for embryonic axis formation [13] . GPR177 is a transmembrane protein pivotal to mediating the secretion of Wnt signal proteins, which are essential for regulating neuronal development [14] . Recently, Fu et al [15] found that loss of GPR177 in the Wnt1-expressing cells causes abnormalities of mid/hindbrain and craniofacial defects.
Chromosome 1p32-p31 deletion with haploinsufficiency of the NFIA gene in the present case was rapidly diagnosed by aCGH using uncultured amniocytes obtained by late amniocentesis in the third trimester. Rapid genome-wide aneuploidy diagnosis using uncultured amniocytes and aCGH in pregnancy with abnormal ultrasound findings detected in late second and third trimesters have been well described [16, 17] . Application of aCGH using uncultured amniocytes obtained by amniocentesis in late gestation, as shown in this case, is less invasive and more efficient in rapid aneuploidy diagnosis of subtle chromosome aberrations as well as identification of the candidate gene responsible for the specific phenotype.
In addition to 1p32-p31 deletion, at least 17 ACC significant critical regions, including 12 Class I regions have been identified, such as 1p36 deletion, 1q41-q42 deletion, 1q43-q44 deletion, 4p16.1-p16.3 deletion, 6p25 deletion, 6q26-q27 deletion, 8p22-p21.3 duplication, 9q34.3 deletion, 11q25 duplication, 13q32.3-q33.1 deletion, 13q34 duplication, 14q12-q13.1 deletion, 14q32.3 deletion, 21q22.11-q22.3 duplication, 21q22.2-q22.3 deletion, Xp22.3 deletion, and Xq27.3-q28 duplication [18] . In addition to NFIA at 1p31.3-p31.2, other candidate genes associated with ACC include AKT3 (OMIM 611223) at 1q44 [19, 20] , DISP1 (OMIM 607502) at 1q41 [21] , FOXG1 (OMIM 164874) at 14q13
[22e24], and ZIC2 (OMIM 603073) at 13q32 [18] .
In conclusion, prenatal diagnosis of ventriculomegaly with an abnormal corpus callosum should alert subtle chromosome aberrations and prompt molecular cytogenetic investigation if necessary. The present case provides evidence that fetuses with chromosome 1p32-p31 deletion syndrome and haploinsufficiency of the NFIA gene may present ventriculomegaly, corpus callosum hypogenesis, abnormal external genitalia, and intrauterine growth restriction in the third trimester.
